SCHEMBL14010965

SCHEMBL14010965

CC(=O)OCc1cc(Cc2cc(COC(C)=O)cc(C(C)(C)C)c2O)c(O)c(C(C)(C)C)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSPA5 P11021 2/20 0.59
▸ HIF1A Q16665 4/20 0.49
▸ CYP2C9 P11712 3/20 0.49
▸ CYP2C19 P33261 3/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ CYP2D6 P10635 2/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ ALDH1A1 P00352 5/20 0.41
▸ GAA P10253 5/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ CYP3A4 P08684 3/20 0.40
▸ TSHR P16473 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ BLM P54132 2/20 0.40
▸ ATM Q13315 2/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL931514 0.89 ALDH1A1 (0.51) HIF1ACYP2C9CYP2C19SMN1; SMN2CYP2D6
SCHEMBL14000579 0.85 HSPA5 (0.60) HSPA5HIF1ACYP2C9CYP2C19SMN1; SMN2
Phosphoric Acid SCHEMBL15754223 0.83 HMGCR (0.47) HIF1ACYP2C9CYP2C19CYP2D6ALDH1A1
SCHEMBL14219924 0.83 HSPA5 (0.54) HSPA5HIF1ACYP2C9CYP2C19SMN1; SMN2
SCHEMBL14003041 0.82 HSPA5 (0.52) HSPA5HIF1ACYP2C9CYP2C19SMN1; SMN2
SCHEMBL14000581 0.81 HSPA5 (0.55) HSPA5HIF1ACYP2C9CYP2C19SMN1; SMN2
SCHEMBL14000559 0.81 HSPA5 (0.67) HSPA5HIF1ACYP2C9CYP2C19SMN1; SMN2
SCHEMBL14000556 0.79 HMGCR (0.41) HSPA5HIF1ACYP2C9CYP2C19SMN1; SMN2
SCHEMBL14003040 0.79 TNKS2 (0.50) HSPA5HIF1ACYP2C9CYP2C19SMN1; SMN2
SCHEMBL14003023 0.78 HSPA5 (0.48) HSPA5HIF1ACYP2C9CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7455960-B2 Photothermographic material FUJIFILM CORPORATION (JP) 2008-11-25 — — US disclosed
US-20070026349-A1 when parallel light having the same wavelength as a main emission peak wavelength of the fluorescent intensifying screen is incident perpendicular to the material surface, the parallel light component of transmitted light comprises 5% or more of the incident light; for medical use having high sensitivity FUJI PHOTO FILM CO., LTD. 2007-02-01 — — US disclosed
US-20070026349-A1 when parallel light having the same wavelength as a main emission peak wavelength of the fluorescent intensifying screen is incident perpendicular to the material surface, the parallel light component of transmitted light comprises 5% or more of the incident light; for medical use having high sensitivity FUJI PHOTO FILM CO., LTD. 2007-02-01 — — US disclosed
Send feedback